Click to Enlarge
Interventional Catheterization
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| PEDIATRIX CARDIOLOGY ASSOCIATES OF NEW MEXICO |
| PDA |
| After Coil Occlusion |
*
| PDA closure with Amplatzer PDA device |
PEDIATRIX CARDIOLOGIST FIRST IN NEW MEXICO TO REPLACE
HEART VALVE WITHOUT SURGERY
In the past, when patients needed a heart valve replacement, they had to
undergo open-heart surgery with cardiopulmonary bypass. On
September 8, 2011, Dr. Jennifer Davenport of Pediatrix Cardiology
Associates of New Mexico, performed percutaneous replacement of a
pulmonary valve in a patient at Presbyterian Hospital in Albuquerque,
using the Melody® Valve, thereby obviating the need for open-heart
surgery. In doing so, she became the first and, currently, the only
physician in New Mexico certified to offer this procedure.
The percutaneous technique used for Melody® Valve implantation
involves placing the valve in the heart through an interventional catheter;
meaning that the patient’s heart is accessed via a flexible, hollow tube
(the catheter) inserted through a leg or neck vein, rather than by
opening a patient’s chest. In general, percutaneous procedures are less
invasive than open-heart surgery. Many percutaneous procedures,
including the percutaneous, transcatheter implantable pulmonary valve
procedure, require only one night in hospital. In contrast, open-heart
surgery for heart valve replacement typically requires a 4-5 day stay at
minimum. For patients in need of pulmonary valve repair or replacement
and who are candidates for the procedure, the Melody® Valve implant
means there is no need for cardiopulmonary bypass (external, mechanical
circulation of the body’s blood), and therefore, patients have a lower risk
of complications and there is no scarring.
The Melody® Valve was first developed in the U.K. in 2001 and gained
FDA approval for use in the U.S. in 2010. It is manufactured by
Medtronic, and similar to many animal-sourced surgical implants, is
constructed of bovine jugular vein valves.
Dr. Davenport completed her undergraduate medical education at the
University of Kansas Medical Center. She completed a pediatric residency
at Miami Children’s Hospital and then did fellowships in pediatric
cardiology at Texas Children’s Hospital and the University of California,
San Francisco. Following this she became Director of Interventional
Cardiology at UC Davis. Dr. Davenport joined Pediatrix Cardiology
Associates of New Mexico in October, 2010. She and her colleagues offer
comprehensive pediatric and congenital cardiology services, in
partnership with Presbyterian Hospital.
To learn more about the Melody® Valve and it's use in pediatrics, visit:
http://www.medtronic.com/melody/index.html
HEART VALVE WITHOUT SURGERY
In the past, when patients needed a heart valve replacement, they had to
undergo open-heart surgery with cardiopulmonary bypass. On
September 8, 2011, Dr. Jennifer Davenport of Pediatrix Cardiology
Associates of New Mexico, performed percutaneous replacement of a
pulmonary valve in a patient at Presbyterian Hospital in Albuquerque,
using the Melody® Valve, thereby obviating the need for open-heart
surgery. In doing so, she became the first and, currently, the only
physician in New Mexico certified to offer this procedure.
The percutaneous technique used for Melody® Valve implantation
involves placing the valve in the heart through an interventional catheter;
meaning that the patient’s heart is accessed via a flexible, hollow tube
(the catheter) inserted through a leg or neck vein, rather than by
opening a patient’s chest. In general, percutaneous procedures are less
invasive than open-heart surgery. Many percutaneous procedures,
including the percutaneous, transcatheter implantable pulmonary valve
procedure, require only one night in hospital. In contrast, open-heart
surgery for heart valve replacement typically requires a 4-5 day stay at
minimum. For patients in need of pulmonary valve repair or replacement
and who are candidates for the procedure, the Melody® Valve implant
means there is no need for cardiopulmonary bypass (external, mechanical
circulation of the body’s blood), and therefore, patients have a lower risk
of complications and there is no scarring.
The Melody® Valve was first developed in the U.K. in 2001 and gained
FDA approval for use in the U.S. in 2010. It is manufactured by
Medtronic, and similar to many animal-sourced surgical implants, is
constructed of bovine jugular vein valves.
Dr. Davenport completed her undergraduate medical education at the
University of Kansas Medical Center. She completed a pediatric residency
at Miami Children’s Hospital and then did fellowships in pediatric
cardiology at Texas Children’s Hospital and the University of California,
San Francisco. Following this she became Director of Interventional
Cardiology at UC Davis. Dr. Davenport joined Pediatrix Cardiology
Associates of New Mexico in October, 2010. She and her colleagues offer
comprehensive pediatric and congenital cardiology services, in
partnership with Presbyterian Hospital.
To learn more about the Melody® Valve and it's use in pediatrics, visit:
http://www.medtronic.com/melody/index.html